8189 — Tianjin Teda Biomedical Engineering Co Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapSucker Stock

Market Cap
HK$458.81m
Enterprise Value
HK$540.62m
Revenue
CNY522.97m

Annual balance sheet for Tianjin Teda Biomedical Engineering Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	C2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	29.8	9.55	5.93	25.4	29.2
Net Total Accounts Receivable
Net Total Receivables	42.9	45.1	18.2	14.3	18.2
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	209	193	190	234	190
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	139	132	113	98.4	75
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	348	337	303	333	265
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	192	218	217	279	252
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Liabilities	247	267	253	310	253
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	101	70.1	50	22.1	12.2
Total Liabilities & Shareholders' Equity	348	337	303	333	265
Total Common Shares Outstanding